Lithuania: Difference between revisions
| Line 33: | Line 33: | ||
=== [[hasClinicalGuidelines::Ministry_of_Health_Protection_Protocols_(Lithuania)|Ministry of Health Protection Protocols]] === | === [[hasClinicalGuidelines::Ministry_of_Health_Protection_Protocols_(Lithuania)|Ministry of Health Protection Protocols]] === | ||
=== [[hasClinicalGuidelines::LNDTA_Guidelines_(Lithuania)|LNDTA Guidelines]] === | === [[hasClinicalGuidelines::LNDTA_Guidelines_(Lithuania)|LNDTA Guidelines]] === | ||
Revision as of 17:33, 20 May 2024
Go back to Cancer Centers list.
Cancer Centers
Healthcare System
Administrative or Claims Data
Database: Cancer Prevention Statistics
Database: Activities of in-patient beds
Database: Cancer Procedures
Database: Disease Incidence and Prevalence
Registries
Clinical Practices Guidelines
Ministry of Health Protection Protocols
LNDTA Guidelines
Sponsor, manager or home institution: Lietuvos nefrologijos, dializės ir transplantacijos asociacijos.
Primary purpose: To prepare recommendations on how to optimize the diagnosis and treatment of kidney diseases.
Type of information: Recommendations, diagnosis, monitoring, evaluation and treatments of kidney diseases.
Access to information: List of guidelines [1].
LPAD Guideline
Sponsor, manager or home institution: Ietuvos pulmonologų ir alergologų draugija.
Primary purpose: To guide health care professionals in diagnosing and treating lung cancer, considering the patient's individual needs, preferences, values, and characteristics.
Type of information: Epidemiology, diagnostics, treatments, palliative care, quality of life, follow up of lung cancers.
Access to information: Access information [2].
Latest Policymaking Initiatives
Reports: Health statistics publications
Sponsor, manager or home institution: Higienus Intitutas.
Primary purpose: To present statistical information and data analysis related to specific health topics and healthcare aspects in Lithuania.
Type of information: Incidence, morbidity and mortality of malignant tumors; Rate of death from malignant tumors; Population (percentage) that participated in breast and cervical cancer prevention programs.
Data level: National and regional level.
Access to information: Access Information [3]. Screenings information [4].
Report: EU Country Cancer Profile 2023
Sponsor, manager or home institution: OECD and European Commission.
Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
Type of information: National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care.
Data level: National level.
Access to information: Access Information [5].
Patients Communities
Sponsor, manager or home institution: Various institutions.
Primary purpose: To provide support, information, advocacy, and a sense of community for individuals affected by cancer, aiming to improve their quality of life and promote awareness, research, and better care.
Access to information: Information [6].
Compilation: ESMO Patient Guides
Sponsor, manager or home institution: European Society for Medical Oncology.
Primary purpose: To translate complex medical language into understandable information for patients.
Available guides: Surviving Cancer; AML; Follicular lymphoma; CML; Glioblastoma; Bone Sarcoma; Soft Tissue Sarcomas; Colorectal Cancer; Breast Cancer; Squamous Cell Carcinoma of the Head and Neck Region; Cancer of the Uterus (Endometrium).
Type of information: Information on each guide varies for each cancer type. Generally, guides provide definitions, explanations of causes, diagnosis, treatment, treatment options, care after treatment, among others.
Access to information: List of guides [7].
